A recent study in the Journal of Gastrointestinal Cancer found that 22 cases of colorectal cancer (CRC) occurred over 10,000 person-years after endoscopic mucosal resection (EMR). The research highlights a low but measurable CRC risk following this procedure, with an incidence rate of 2.16 per 1,000 person-years. Of the population, 2,735 patients were at risk at the start of follow-up, and a sensitivity analysis limited to patients aged 50 to 75 years yielded a nearly identical estimate of 2.14 per 1,000 person-years (95% CI, 1.29-3.34).
EMR has become a standard, colon-preserving alternative to surgery for large or flat colorectal lesions not removable by standard polypectomy. However, outcomes vary based on lesion size, morphology, resection technique, and follow-up. A prior meta-analysis found local recurrence in 15% of nonpedunculated lesions after EMR. The procedure’s effectiveness depends on the completeness of excision, which can influence long-term outcomes, including CRC risk.
Read Also: Atopic Dermatitis Care Delayed by Payer Rules, Poor Tracking
Studying Real-World CRC Risk After EMR
While local adenoma recurrence after EMR has been documented, less is known about subsequent CRC diagnoses in real-world populations. Researchers used the TriNetX US Collaborative Network, which includes 66 healthcare organizations, to identify patients aged 40 or older who underwent colonoscopy or sigmoidoscopy with EMR between January 1, 2016, and January 1, 2017. After a 1-year washout period to exclude synchronous or procedure-related cancers, they assessed CRC diagnoses from 2018 to 2021.
The cohort included 3,081 patients with a mean age of 62.9 years (SD 8.89); 52% were female, and 76% were White. Over 10,187.8 person-years, 22 patients were diagnosed with CRC, for an incidence of 2.16 per 1,000 person-years (95% CI, 1.35-3.27). Because each calendar year contained 10 or fewer events, annual rates could not be estimated.
CRC Incidence by Demographics
The study found a CRC incidence of 2.54 per 1,000 person-years (95% CI, 1.31-4.44) in men and 1.83 (95% CI, 0.88-3.36) in women. White patients had an incidence of 1.94 per 1,000 person-years (95% CI, 1.09-3.20), whereas Black, Asian, and unknown-race patients combined had a higher point estimate of 3.16 per 1,000 person-years (95% CI, 1.27-6.52). However, this comparison was based on only 7 events across these groups, with individual racial cohort counts masked for privacy and overlapping confidence intervals across all groups.
Read Also: Short US residence tied to less screening
During the 5 years after the index procedure, 3.9% of patients underwent repeat EMR, 0.9% underwent colorectal surgery, and 42.9% received a subsequent colorectal polyp diagnosis. The high polyp rate suggested ongoing surveillance, though the codes could not distinguish between residual, recurrent, or new lesions. No endoscopic submucosal dissection procedures were identified during this period.
Limitations and Future Directions
J Gastrointest Cancer. 2026;57:256. doi:10.1007/s12029-026-01634-4 Belderbos TD, Leenders M, Moons LM, Siersema PD. The researchers emphasized the need for future studies linking EHR data to endoscopy reports, pathology, lesion location, resection technique, margin treatment, surveillance completion, and care outside the index health system. Such research could identify preventable CRC mechanisms after EMR and guide equitable surveillance strategies.
